X

Biochemistry research company picks IBM

Proteome Systems, a biotechnology research company with offices in Australia and Boston, has purchased IBM products for its own use and will sell IBM hardware and software preferentially to customers using its software, the companies said Tuesday. Proteome Systems sells hardware systems for analyzing proteins, complex molecules derived from genes. Proteomics research is a part of medical research and drug development. The company will sell IBM pSeries Unix servers and its DB2 database software.

Stephen Shankland Former Principal Writer
Stephen Shankland worked at CNET from 1998 to 2024 and wrote about processors, digital photography, AI, quantum computing, computer science, materials science, supercomputers, drones, browsers, 3D printing, USB, and new computing technology in general. He has a soft spot in his heart for standards groups and I/O interfaces. His first big scoop was about radioactive cat poop.
Expertise Processors, semiconductors, web browsers, quantum computing, supercomputers, AI, 3D printing, drones, computer science, physics, programming, materials science, USB, UWB, Android, digital photography, science. Credentials
  • Shankland covered the tech industry for more than 25 years and was a science writer for five years before that. He has deep expertise in microprocessors, digital photography, computer hardware and software, internet standards, web technology, and more.
See full bio
Stephen Shankland
Proteome Systems, a biotechnology research company with offices in Australia and Boston, has purchased IBM products for its own use and will sell IBM hardware and software preferentially to customers using its software, the companies said Tuesday.

Proteome Systems sells hardware systems for analyzing proteins, complex molecules derived from genes. Proteomics research is a part of medical research and drug development. The company will sell IBM pSeries Unix servers and its DB2 database software.